|
Originally published In Press as doi:10.1074/jbc.M604713200 on June 30, 2006
Originally published In Press as doi:10.1074/jbc.M604713200 on June 29, 2006
Originally published In Press as doi:10.1074/jbc.M604713200 on June 27, 2006
J. Biol. Chem., Vol. 281, Issue 34, 24695-24703, August 25, 2006
Acid Ceramidase but Not Acid Sphingomyelinase Is Required for Tumor Necrosis Factor- -induced PGE2 Production*
Youssef H. Zeidan ,
Benjamin J. Pettus ,
Saeed Elojeimy ,
Tarek Taha ,
Lina M. Obeid ¶||,
Toshihiko Kawamori**,
James S. Norris , and
Yusuf A. Hannun 1
From the
Departments of Biochemistry and Molecular Biology, Microbiology and Immunology, **Pathology and Laboratory Medicine, and ||Medicine, Medical University of South Carolina, Charleston, South Carolina 29425 and the ¶Department of Veterans Affairs Medical Center, Charleston, South Carolina 29401
Sphingolipids are well established effectors of signal transduction downstream of the tumor necrosis factor (TNF) receptor. In a previous study, we showed that the sphingosine kinase/sphingosine 1-phosphate (S1P) pathway couples TNF receptor to induction of the cyclooxygenase 2 gene and prostaglandin synthesis (Pettus, B. J., Bielawski, J., Porcelli, A. M., Reames, D. L., Johnson, K. R., Morrow, J., Chalfant, C. E., Obeid, L. M., and Hannun, Y. A. (2003) FASEB J. 17, 1411-1421). In this study, the requirement for acid sphingomyelinase and sphingomyelin metabolites in the TNF /prostaglandin E2 (PGE2) pathway was investigated. The amphiphilic compound desipramine, a frequently employed inhibitor of acid sphingomyelinase (ASMase), blocked PGE2 production. However, the action of desipramine was independent of its action on ASMase, since neither genetic loss of ASMase (Niemann-Pick fibroblasts) nor knockdown of ASMase using RNA interference affected TNF -induced PGE2 synthesis. Further investigations revealed that desipramine down-regulated acid ceramidase (AC), but not sphingosine kinase, at the protein level. This resulted in a time-dependent drop in sphingosine and S1P levels. Moreover, exogenous administration of either sphingosine or S1P rescued PGE2 biosynthesis after desipramine treatment. Interestingly, knockdown of endogenous AC by RNA interference attenuated cyclooxygenase 2 induction by TNF and subsequent PGE2 biosynthesis. Taken together, these results define a novel role for AC in the TNF /PGE2 pathway. In addition, the results of this study warrant careful reconsideration of desipramine as a specific inhibitor for ASMase.
Received for publication, May 17, 2006
* This work was supported in part by National Institutes of Health Grants CA87584 (to Y. A. H.), GM62887 (to L. M. O.), Hollings Cancer Center Dept. of Defense Grant GC3532-03-42153CM, Center of Biomedical Research Excellence Grant P20-RR017677 (to T. K.), and a MERIT Award by the Office of Research and Development, Dept. of Veterans Affairs, Ralph H. Johnson Veterans Affairs Medical Center (Charleston, SC) (to L. M. O.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains supplemental Fig. 1.
1 To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology Medical University of South Carolina, 175 Ashley Ave., P.O. Box 250509, Charleston, SC 29425. Tel.: 843-792-9318; Fax: 843-792-4322; E-mail: hannun{at}musc.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Uhlig and E. Gulbins
Sphingolipids in the Lungs
Am. J. Respir. Crit. Care Med.,
December 1, 2008;
178(11):
1100 - 1114.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Chudakova, Y. H. Zeidan, B. W. Wheeler, J. Yu, S. A. Novgorodov, M. S. Kindy, Y. A. Hannun, and T. I. Gudz
Integrin-associated Lyn Kinase Promotes Cell Survival by Suppressing Acid Sphingomyelinase Activity
J. Biol. Chem.,
October 24, 2008;
283(43):
28806 - 28816.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Jin, Q. Hou, T. D. Mullen, Y. H. Zeidan, J. Bielawski, J. M. Kraveka, A. Bielawska, L. M. Obeid, Y. A. Hannun, and Y.-T. Hsu
Ceramide Generated by Sphingomyelin Hydrolysis and the Salvage Pathway Is Involved in Hypoxia/Reoxygenation-induced Bax Redistribution to Mitochondria in NT-2 Cells
J. Biol. Chem.,
September 26, 2008;
283(39):
26509 - 26517.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. H. Zeidan, R. W. Jenkins, and Y. A. Hannun
Remodeling of cellular cytoskeleton by the acid sphingomyelinase/ceramide pathway
J. Cell Biol.,
April 21, 2008;
181(2):
335 - 350.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. H. Zeidan, B. X. Wu, R. W. Jenkins, L. M. Obeid, and Y. A. Hannun
A novel role for protein kinase C{delta}-mediated phosphorylation of acid sphingomyelinase in UV light-induced mitochondrial injury
FASEB J,
January 1, 2008;
22(1):
183 - 193.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. H. Zeidan and Y. A. Hannun
Activation of Acid Sphingomyelinase by Protein Kinase C{delta}-mediated Phosphorylation
J. Biol. Chem.,
April 13, 2007;
282(15):
11549 - 11561.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|